ResearcherSun Yat-sen UniversityNo recent work listed

Yang Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5934-1537; OpenAlex author ID A5080111491. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

A Cyclodiaryliodonium NOX Inhibitor for the Treatment of Pancreatic Cancer via Enzyme-Activatable Targeted Delivery by Sulfated Glycosaminoglycan Derivatives. Last author DOI 10.1002/adhm.202203011 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shengping Li · 1 shared paper, 2023 · strength 0.17
- Paper A Cyclodiaryliodonium NOX Inhibitor for the Treatment of Pancreatic Cancer via Enzyme-Activatable Targeted Delivery by … DOI 10.1002/adhm.202203011 ↗
Jiadong Pang · 1 shared paper, 2023 · strength 0.17
- Paper A Cyclodiaryliodonium NOX Inhibitor for the Treatment of Pancreatic Cancer via Enzyme-Activatable Targeted Delivery by … DOI 10.1002/adhm.202203011 ↗
Xiaobing Li · 1 shared paper, 2023 · strength 0.17
- Paper A Cyclodiaryliodonium NOX Inhibitor for the Treatment of Pancreatic Cancer via Enzyme-Activatable Targeted Delivery by … DOI 10.1002/adhm.202203011 ↗
Peng Huang · 1 shared paper, 2023 · strength 0.17
- Paper A Cyclodiaryliodonium NOX Inhibitor for the Treatment of Pancreatic Cancer via Enzyme-Activatable Targeted Delivery by … DOI 10.1002/adhm.202203011 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.